Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement

Executive Summary

• Izotropic Corporation announced its intention to complete a non‑brokered private placement of 1,200,000 units at $0.25 per unit, targeting gross proceeds of up to $300,000.
• Each unit consists of one common share and one transferable warrant allowing the purchase of an additional share at $0.25 for three years.
• Proceeds will be used for general working capital to support commercialization of the IzoView Breast CT system and related corporate activities.

Key Details

• Offering Size: 1,200,000 units
• Unit Price: $0.25 per unit
• Gross Proceeds Target: up to $300,000
• Composition of Each Unit: 1 common share + 1 transferable warrant
• Warrant Terms: Right to purchase one additional share at $0.25 per share; exercisable for three (3) years from closing.
• Use of Proceeds: General working capital, including funding commercialization efforts for IzoView Breast CT and related corporate needs.
• Statutory Hold Period: Securities subject to a four‑month‑plus‑one‑day hold period under applicable securities legislation.
• Regulatory Conditions: Completion contingent on receipt of all necessary regulatory approvals; securities not registered in the United States and may only be offered/sold there pursuant to an exemption or registration.

Notable Quotes

(No direct quotes were provided in the release.)